Phenytoin
FDA Approved
Description
Phenytoin is a first-generation anticonvulsant medication used to control seizures. Maternal use during pregnancy is a known cause of fetal anticonvulsant syndrome, resulting in craniofacial abnormalities, growth restriction, and developmental delays. The drug stabilizes neuronal membranes by modulating sodium channels.
Indications & Therapeutic Use
Tonic-clonic seizures, Partial seizures, Status epilepticus
Linked Diseases:
Global Availability (8 countries)
| Country | Access Route | Regulatory Pathway | Lead Time | Status |
|---|---|---|---|---|
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — | |
| — | — | — | — |
Available Through
This drug is available for procurement through the following fulfilment partner.
Fulfilment Partner
Phenytoin
| Generic Name | Phenytoin |
| Brands | 1 brand available |
| Active Ingredient | Phenytoin Sodium |
| Drug Class | Tonic-clonic seizures |
| Manufacturer | Pfizer Inc. |
| Dosage Forms | Oral capsules 100mg; Oral suspension 125mg/5mL; IV injection 50mg/mL |
| Medical Code | N03AB02 |
| Orphan Status | No |
| Cold Chain | Not Required |
| Lead Time | 5 days |
| Reg. Status | FDA Approved |
| Countries | 8 countries |
Authority Signals
Last Verified3/21/2026
Data ConfidenceHigh (AI + Pharmacist)
Source Citations9 Validated Nodes